Three case reports of emergent dyskinesia with clozapine

  • Gafoor R
  • Brophy J
  • 10


    Mendeley users who have this article in their library.
  • 9


    Citations of this article.


Clozapine is indicated for the treatment of patients intolerant of conventional antipsychotic agents. It is often used to treat those patients who have developed movement disorders while on conventional antipsychotics. We report three cases of dyskinesia associated with clozapine induction. We suggest a mechanism that might explain an underlying dopaminergic hypersensitivity during this transitional period. Further, we identify groups that might be at high risk of developing dyskinesia and suggest strategies to reduce risk especially in these groups. © 2003 Éditions scientifiques et médicales Elsevier SAS. All rights reserved.

Author-supplied keywords

  • Clozapine
  • Emergent dyskinesia
  • Movement disorders
  • Schizophrenia
  • Tardive dyskinesia
  • Withdrawal dyskinesia

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Rafael Gafoor

  • Justin Brophy

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free